Table 6.
Test formulations | NTM-PNLC-GEL | NTM-PNLC | Natacyn | |
---|---|---|---|---|
Dose | 0.3 mg | 0.3 mg | 5 mg | |
PK parameter | Units | |||
AUC0–t | μg/μL × h | 1.15 ± 0.02 | 0.58 ± 0.01a | 2.72 ± 0.17b |
Dose normalized AUC0–t | (μg/μL × h)/mg | 3.83 ± 0.06 | 1.93 ± 0.03a | 0.54 ± 0.03b |
T0.5 | h | 2.82 ± 0.23 | 0.93 ± 0.14a | 2.78 ± 0.85 |
Cmax | μg/μL | 2.57 ± 0.09 | 1.37 ± 0.06a | 3.00 ± 0.18b |
Dose normalized Cmax | (μg/μL)/mg | 8.57 ± 0.3 | 4.56 ± 0.2a | 0.6 ± 0.03b |
MRT0–∞ | h | 2.16 ± 0.26 | 1.09 ± 0.21a | 1.56 ± 0.32 |
Statistically significant difference between NTM-PNLC-GEL and NTM-PNLC at P < 0.05.
Statistically significant difference between NTM-PNLC-GEL and Natacyn (5%) at P < 0.05.
AUC, area under curve; Cmax, maximum concentration; MRT, mean residence time; PK, pharmacokinetics; T0.5, half-life.